PTHS Q1 2026 Earnings Pelthos Therapeutics Surprises with NarrowerThanExpected Loss in Q1 2026 LARK Q1 2026 Earnings EPS of 083 Reported Stock Declines Slightly ORKT Q0 2024 Earnings Substantial EPS Miss as Revenue Remains Undisclosed Indian Equities Remain Under Foreign Selling Pressure Amid Outperformance of US Markets Value Investing Opportunities at Market Lows A Cautious Perspective for Seeking Undervalued Stocks Zepp Health Q3 2025 Earnings Narrowing Losses Drive Modest Stock Uplift